Eliot Engel actually said...

"I am encouraged by the advances we have made into the causes and mechanisms of these diseases, as well as our progress toward treatments, but, obviously, we still have a long way to go."

"I have worked to be a voice with those with rare and orphan diseases."

"If we insist on a no enrichment requirement, there are two consequences: We don't have good visibility into a country's nuclear program and our nuclear companies lose market share and become less viab..."

"I would urge the committee to reconsider that 2011 bill by marking up identical Ros-Lehtinen/Brad Sherman legislation, H.R. 3766."